Publications by authors named "Ralph Corey"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

3,719

Total Likes

267

Extended Reach

2,226,826

Social Features

142
A
Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Khaldoun G Tarakji, Suneet Mittal, Charles Kennergren, Ralph Corey, Jeanne E Poole, Edward Schloss, Jose Gallastegui, Robert A Pickett, Rudolph Evonich, François Philippon

N Engl J Med· May 2019

Videos about Article: user user

2 9 140 4 59

View All Article and Social Media Activity
C
Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial.
M Rizwan Sohail, G Ralph Corey, Bruce L Wilkoff, Jeanne E Poole, Suneet Mittal

JACC Clin Electrophysiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
Bruce L Wilkoff, Giuseppe Boriani, Suneet Mittal, Jeanne E Poole, Charles Kennergren, G Ralph Corey

Circ Arrhythm Electrophysiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Suneet Mittal, Bruce L Wilkoff, Charles Kennergren, Jeanne E Poole, Ralph Corey

Heart Rhythm· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.
Vance G Fowler, Anita F Das, Joy Lipka-Diamond, Raymond Schuch, Roger Pomerantz, G Ralph Corey

J Clin Invest· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
Bruce L Wilkoff, Giuseppe Boriani, Suneet Mittal, Jeanne E Poole, Charles Kennergren, G Ralph Corey

Circ Arrhythm Electrophysiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections.
Stephanie Noviello, G Ralph Corey, Thomas L Holland, Thomas Lodise, William O'Riordan

J Med Microbiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
Ian Morrissey, Stephen Hawser, Sibylle H Lob, James A Karlowsky, Matteo Bassetti, G Ralph Corey, Corey Fyfe

Antimicrob Agents Chemother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
Ian Morrissey, Melanie Olesky, Stephen Hawser, Sibylle H Lob, James A Karlowsky, G Ralph Corey, Corey Fyfe

Antimicrob Agents Chemother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy.
Tulika Singh, Cesar A Lopez, Camila Giuberti, Maria L Dennis, Hannah L Itell, Ralph G Corey

PLoS Negl Trop Dis· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials.
Ralph Corey, Gregory Moran, Richard Goering, Mekki Bensaci, Taylor Sandison

Diagn Microbiol Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.
G Ralph Corey, Mark H Wilcox, Jesus Gonzalez, Alena Jandourek, David J Wilson

Int J Antimicrob Agents· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies.
David B Huang, Stephanie Noviello, Barbara Balser, Amy Scaramucci, G Ralph Corey

Clin Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.
Sarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, Mical Paul, Dafna Yahav, G Ralph Corey

Clin Infect Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.
G Ralph Corey, Jamie A McKinnell, Michael J Rybak

Clin Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults.
Thomas L Holland, Henry F Chambers, Helen W Boucher, G Ralph Corey, Rebecca Coleman

Clin Infect Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe.
David B Huang, Sophie Magnet, Stefania De Angelis, Thomas L Holland, Thomas M File, G Ralph Corey

Diagn Microbiol Infect Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iclaprim: a differentiated option for the treatment of skin and skin structure infections.
Stephanie Noviello, David B Huang, G Ralph Corey

Expert Rev Anti Infect Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Delafloxacin: Focus on Adverse Events of Special Interest.
Thomas Lodise, Ralph Corey, David Hooper, Sue Cammarata

Open Forum Infect Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.
Thomas L Holland, Issam Raad, Helen W Boucher, Deverick J Anderson, Sara E Cosgrove, G Ralph Corey

JAMA· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections.
David B Huang, G Ralph Corey, Thomas L Holland, Thomas Lodise, William O'Riordan

Int J Antimicrob Agents· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study).
Thomas L Holland, William O'Riordan, Alison McManus, Elliot Shin, Ali Borghei, G Ralph Corey

Antimicrob Agents Chemother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1.
David B Huang, William O'Riordan, J Scott Overcash, Barry Heller, Faisal Amin, G Ralph Corey

Clin Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe.
David B Huang, Thomas M File, Matthew Dryden, G Ralph Corey, Antoni Torres

Diagn Microbiol Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.
G Ralph Corey, Jeffery Loutit, Greg Moeck, Matthew Wikler, Michael N Dudley

Antimicrob Agents Chemother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis